These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates. Gane EJ, Patterson S, Strasser SI, McCaughan GW, Angus PW. Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403 [Abstract] [Full Text] [Related]
10. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation. Cholongitas E, Goulis I, Antoniadis N, Fouzas I, Imvrios G, Giakoustidis D, Giouleme O, Papanikolaou V, Akriviadis E, Vasiliadis T. Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122 [Abstract] [Full Text] [Related]
19. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis. Wadhawan M, Gupta S, Goyal N, Taneja S, Kumar A. Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470 [Abstract] [Full Text] [Related]